-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Reports In-Line Q4 EPS
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Misses Q3 EPS by 1c, Misses on Revenue
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Announces Repurchase of Approximately $170M of Convertible Notes
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Tops Q3 EPS by 15c
-
-
-
-
-
-
487,375 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


